Skip to main content
TipRanks
Go Ultimate75% OFF

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (T14) Share Price & Analysis

8 Followers

T14 Stock Chart & Stats

$2.50-$0.03(-1.19%)
At close: 5:00 PM GMT+8
$2.5$2.55$2.6$2.65Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$2.50 - $2.53
52-Week Range
$2.45 - $3.75
Previous Close
$2.53
Volume
N/A
Average Volume (3M)
185.64K
Market Cap
$3.80B
Enterprise Value
$1.77B
Total Cash (Recent Filing)
$1.31B
Total Debt (Recent Filing)
$94.90M
Price to Earnings (P/E)
33.2
Beta
0.26
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
13.96%

Bulls Say, Bears Say

Bulls Say

Very Low Leverage

Debt-to-equity of about 0.02 across the TTM and prior years indicates a conservative capital structure with limited solvency pressure. This gives the company flexibility to fund product development, operations, or growth initiatives without substantial balance-sheet strain.

Strong Profit Margins

High TTM gross, operating, and net margins show that the company retains meaningful economics from its pharmaceutical portfolio. This profitability provides internal funding capacity and may help absorb moderate pricing, product-mix, or revenue pressures over the next several quarters.

Positive Free Cash Flow

Positive operating and free cash flow, with free cash flow representing roughly 83% of net income, supports the quality of reported earnings. Sustained cash generation can fund investment, dividends, and working needs while reducing reliance on external financing.

Bears Say

Revenue Contraction

Persistent revenue contraction indicates weakening top-line momentum across the company’s pharmaceutical portfolio rather than a single isolated reporting-period issue. Continued declines could reduce operating leverage, limit reinvestment capacity, and make future profit growth harder to sustain.

Sharp Earnings Decline

The substantial step-down from 2025 profitability shows that earnings have normalized or come under pressure after an unusually strong period. Lower earnings power can constrain shareholder returns and reduce the company’s ability to compound investment and product-development spending.

Volatile Cash Conversion

Although cash generation remains positive, negative free-cash-flow growth and inconsistent conversion suggest that working-capital movements are affecting the timing and reliability of cash realization. This may make internally funded investment and shareholder distributions less predictable.

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S News

T14 FAQ

What was Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s price range in the past 12 months?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S lowest share price was $2.45 and its highest was $3.75 in the past 12 months.
What is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s market cap?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s market cap is $3.80B.
When is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s earnings last quarter?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S released its earnings results on Oct 30, 2026. The company reported $0.052 earnings per share for the quarter.
Is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S pay dividends?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S pays an annual dividend of $0.348 which represents an annual dividend yield of 13.96%. See more information on Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S dividends here
What is Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s EPS estimate?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S have?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has 200,000,000 shares outstanding.
What happened to Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s price movement after its last earnings report?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S reported an EPS of $0.052 in its last earnings report. Following the earnings report the stock price went down -0.382%.
Which hedge fund is a major shareholder of Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S?
Currently, no hedge funds are holding shares in SG:T14
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology